Literature DB >> 26385835

The role of robotic surgery in endometrial cancer.

David M O'Malley1, Blair Smith1, Jeffrey M Fowler1.   

Abstract

Robotic surgery for endometrial cancer has less blood loss, shorter hospital stays, and less postoperative complications compared to laparotomies. Robotic technologic advantages over laparoscopic technique are most pronounced in obese patients. The shorter learning curve may explain the greater utilization of the robotic technique. Robotic surgery will continue as a mainstay in the treatment of uterine cancers as we become more efficient and cost conscious while maintaining the high quality outcomes that have been reported.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  endometrial cancer; gynecologic cancer; minimally invasive surgery; robotic surgery; uterine cancer

Mesh:

Year:  2015        PMID: 26385835     DOI: 10.1002/jso.23988

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  4 in total

Review 1.  Endometrial cancer.

Authors:  Vicky Makker; Helen MacKay; Isabelle Ray-Coquard; Douglas A Levine; Shannon N Westin; Daisuke Aoki; Ana Oaknin
Journal:  Nat Rev Dis Primers       Date:  2021-12-09       Impact factor: 65.038

2.  Psychosocial Health Interventions by Social Robots: Systematic Review of Randomized Controlled Trials.

Authors:  Nicole Lee Robinson; Timothy Vaughan Cottier; David John Kavanagh
Journal:  J Med Internet Res       Date:  2019-05-10       Impact factor: 5.428

3.  Robotic surgery in early-stage endometrial cancer.

Authors:  Giacomo Corrado; Simone Bruni; Enrico Vizza
Journal:  Transl Cancer Res       Date:  2019-12       Impact factor: 1.241

Review 4.  Laparotomic versus robotic surgery in elderly patients with endometrial cancer: A systematic review and meta-analysis.

Authors:  Antonio Raffone; Antonio Travaglino; Diego Raimondo; Dominga Boccia; Martino Vetrella; Paolo Verrazzo; Marcello Granata; Paolo Casadio; Luigi Insabato; Antonio Mollo; Renato Seracchioli
Journal:  Int J Gynaecol Obstet       Date:  2021-06-19       Impact factor: 4.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.